Seer (SEER) Change in Cash (2020 - 2026)
Seer (SEER) posted quarterly Change in Cash of $33000.0 for Q1 2026, down 99.72% year-over-year from $11.7 million in Q1 2025, and down 98.57% quarter-over-quarter from $2.3 million in Q4 2025.
Seer (SEER) Change in Cash (2020 - 2026) Analysis & Trends
Seer's Change in Cash history runs 7 years deep, the most recent figure standing at $33000.0 for Q1 2026.
- In Q1 2026, Change in Cash fell 99.72% year-over-year to $33000.0; the TTM figure through Mar 2026 stood at -$5.1 million (down 162.52% YoY), while the FY2025 annual figure was $6.5 million, down 20.86% from the prior year.
- Change in Cash for Q1 2026 stood at $33000.0, down from $2.3 million in the prior quarter.
- The five-year high for Change in Cash was $21.9 million in Q1 2024, with the low at -$146.3 million in Q2 2022.
- The 5-year median for Change in Cash is -$3.9 million (2023), against an average of -$10.9 million.
- Peak annual rise in Change in Cash reached 554.15% in 2024, while the deepest fall reached 380.01% in 2024.
- Seer's Change in Cash stood at -$14.9 million in 2022, then soared by 73.78% to -$3.9 million in 2023, then soared by 180.34% to $3.1 million in 2024, then decreased by 26.16% to $2.3 million in 2025, then plunged by 98.57% to $33000.0 in 2026.
- Business Quant data shows SEER's Change in Cash at $33000.0 in Q1 2026, $2.3 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.24 Mn |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 2.31 Mn |
| Sep 30, 2025 | 7.04 Mn |
| Jun 30, 2025 | -14.51 Mn |
| Mar 31, 2025 | 11.69 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | -22.45 Mn |
| Mar 31, 2024 | 21.90 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | -20.01 Mn |
| Jun 30, 2023 | 8.02 Mn |
| Mar 31, 2023 | -4.82 Mn |
| Dec 31, 2022 | -14.86 Mn |
| Sep 30, 2022 | -10.95 Mn |
| Jun 30, 2022 | -146.31 Mn |
| Mar 31, 2022 | -7.48 Mn |
| Dec 31, 2021 | -98.59 Mn |
| Sep 30, 2021 | -39.27 Mn |